Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment

BACKGROUND. Thrombotic events, arterial or venous in origin, still remain a source of substantial morbidity and mortality in cancer patients. The propensity for their development in oncology patients is partially a consequence of the disease itself and partially a result of our attempts to treat it....

Descripción completa

Detalles Bibliográficos
Autores principales: Perpar, Ana, Brecelj, Erik, Kozjek, Nada Rotovnik, Anderluh, Franc, Oblak, Irena, Vidmar, Marija Skoblar, Velenik, Vaneja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita, Warsaw 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387995/
https://www.ncbi.nlm.nih.gov/pubmed/26029030
http://dx.doi.org/10.2478/raon-2014-0024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387995/
https://www.ncbi.nlm.nih.gov/pubmed/26029030
http://dx.doi.org/10.2478/raon-2014-0024

Ejemplares similares